Prizmah Wound Management
Heals naturally — significantly reducing wound-healing time without complications.
Prizmah for chronic & acute wound healing
Wound healing is a complex process mediated by interacting molecular signals. Autologous growth factors from concentrated platelet suspensions have been used to treat chronic wounds for more than 25 years. Prizmah curbs inflammation, promotes angiogenesis and re-epithelialization, and drives ECM synthesis, collagen production and stem-cell proliferation.
What Prizmah delivers here
Curbs inflammation
Suppresses cytokine release and improves the regeneration process.
Faster healing
By concentrating specific cells, wound-healing time is significantly reduced.
ECM & angiogenesis
Promotes collagen production, capillary angiogenesis and re-epithelialization.
Treated conditions & areas
- Chronic venous ulcers
- Nonhealing diabetic foot ulcers
- Burns and split-thickness skin graft donor sites
- Acute trauma wounds
- Pressure ulcers
- Soft-tissue wound healing
Wound healing with Prizmah, week by week
A representative diabetic foot ulcer treated with Prizmah, documented over three weeks.
Week 0
Debrided diabetic foot ulcer with exposed deep tissue.
Week 1
Fresh granulation tissue begins forming across the wound bed.
Week 2
Healthy red granulation fills the wound, edges contracting.
Week 3
Marked contraction and re-epithelialization of the wound.
Clinical result documented with the Prizmah system. Individual outcomes vary by wound type, protocol and patient.
Ready to bring Prizmah to your practice?
Request a personalised demonstration, or download the clinical brochures to learn more.